Elliptic Labs – Exercise of options under the share option program, share capital increase, and mandatory notification of trade

Following the exercise of share options by option holders under Elliptic Laboratories ASA's ("Elliptic Labs" or the "Company") share option program, the Company's board of directors has, based on the authorization granted by
the general meeting on 23 May 2023, resolved to increase the Company's share capital by a total of NOK 4 825,00, by the issuance of an aggregate 482 500 new shares. 417 880 of the shares have a subscription price of NOK 15.00 per share, and 19 620 of the shares have a subscription price of NOK 3.80 per share.
 
Following registration of the share capital increases pertaining to the issuances of new shares, the share capital will be NOK 1 045 567,10, divided into 104 556 710 shares, each with a par value of NOK 0.01.
 
The primary insider Brian Daly (EVP Sales & Business Development) has exercised 3 756 options, equalling 37 560 shares, under the share option program at a price of NOK 15.00 per share. See the attached form for further details about the transaction.
 
All the exercised options have been granted in accordance with the Company's share option program described in the Company's latest annual financial statements.